Open AccessRecent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage
Author(s) -
Vladislav Vukomanović,
Staša Krasić,
Sergej Prijić,
Sanja Ninić,
Slobodan Popović,
Gordana Petrović,
Snezana Ristic,
Radoje Simić,
Ivana Cerović,
Dejan Nešić
Publication year - 2021
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003260
Subject(s) - medicine , interquartile range , odds ratio , ejection fraction , confidence interval , retrospective cohort study , gastroenterology , myocarditis , c reactive protein , heart failure , inflammation
Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown.